Celgene Corporation (CELG) Releases Quarterly Earnings Results
- Clay Curtis
Geneva Advisors LLC now owns 949,845 shares of the biopharmaceutical company's stock worth $118,189,000 after acquiring an additional 41,500 shares during the period.
In related news, insider Terrie Curran sold 1,727 shares of Celgene Corporation stock in a transaction dated Monday, September 25th. Amgen Inc. now has $127.24 billion valuation. Share performance for the month is now at -31.23%. It has outperformed by 72.65% the S&P500.
Amica Pension Fund Board Of Trustees decreased Intel Corp (INTC) stake by 15.74% reported in 2017Q2 SEC filing. Celgene Corp now has $76.33 billion valuation. It is used to find out the best value stocks, 9 being the best. The stock decreased 0.70% or $1.24 on October 27, reaching $175.28. Following the sale, the director now owns 85,551 shares in the company, valued at $12,110,599.56. It has outperformed by 0.30% the S&P500.
Investors sentiment increased to 1.34 in 2017 Q2. Flagship Harbor Advisors LLC raised its holdings in shares of Celgene Corporation by 0.9% in the 1st quarter. 50 funds opened positions while 74 raised stakes. Amp Cap Invsts reported 0.34% stake. Proshare Advisors Lc accumulated 25,495 shares. Stralem And Co reported 135,405 shares stake. Coastline Trust owns 11,300 shares.
Jag Capital Management Llc who had been investing in Celgene Corp. for a number of months, seems to be bullish on the $77.29 billion market cap company. Sigma Invest Counselors Inc accumulated 0.59% or 29,572 shares. First Allied Advisory Incorporated reported 0.48% stake.
The company now has an insider ownership of 0.2 Percent and Institutional ownership of 81.6 Percent. It also reduced U.S. Bancorp (NYSE:USB) stake by 11,088 shares and now owns 460,945 shares. Bard C R Inc Com (NYSE:BCR) was raised too.
Celgene Corporation (NASDAQ:CELG) received a Buy rating from 8 analysts. Therefore 100% are positive. On average, equities analysts forecast that Celgene Corporation will post $7.32 earnings per share for the current year. Current market cap is $87.66B and the stock has an EPS of $3.22. As per Thursday, August 4, the company rating was maintained by Barclays Capital. On Friday, August 4 the stock rating was maintained by Cowen & Co with "Buy". The firm has "Buy" rating by Liberum Capital given on Tuesday, October 20. Barclays Capital maintained the shares of CELG in report on Friday, October 13 with "Equal-Weight" rating. Credit Suisse initiated the shares of PRTA in report on Thursday, January 21 with "Outperform" rating. Trading volume for Celgene Corporation was 69.76 Million in its previous trading session. Its down 0.10, from 1.25 in 2017Q1. Also, Director Gilla Kaplan sold 7,500 shares of Celgene Corporation stock in a transaction that occurred on Wednesday, August 2nd.
Several institutional investors and hedge funds have recently made changes to their positions in the company. The purchase, at a price of $31.21, resulted in Robert Hugin bringing total 1.06 million shares. Park National Corp OH now owns 3,158 shares of the biopharmaceutical company's stock worth $330,000 after buying an additional 12 shares during the last quarter. Valley National Advisers has 19,565 shares for 0.24% of their portfolio.
But it's not just buying activity that is creating investor interest in CELG; over the last several weeks, several insiders have sold shares. Tnb Fincl has invested 0.89% in Celgene Corporation (NASDAQ:CELG). Arizona State Retirement System holds 193,618 shares. Bokf Na has 86,972 shares. It is positive, as 21 investors sold bluebird bio Inc shares while 53 reduced holdings. Clover Partners L.P. owns 402,238 shares or 3.34% of their U.S. portfolio. Commonwealth Of Pennsylvania School Empls Retrmt has invested 0.12% in Celgene Corporation (NASDAQ:CELG). Hbk Investments Lp holds 0.12% or 104,109 shares in its portfolio. Allstate reported 0.13% stake.
In a report released today, Ian Somaiya from BMO Capital maintained a Buy rating on Celgene (NASDAQ: CELG), with a price target of $148. Therefore 61% are positive. The firm has "Buy" rating given on Thursday, February 18 by Investec. The company was maintained on Thursday, October 26 by Jefferies. BTIG Research downgraded the shares of CELG in report on Wednesday, June 1 to "Neutral" rating.
With a total market value of $0, Celgene Corporation has price-earnings ratio of 30.40 with a one year low of $95.52 and a one year high of $147.17. The firm has "Buy" rating given on Tuesday, October 20 by Panmure Gordon. The rating was upgraded by BMO Capital Markets to "Outperform" on Tuesday, June 6. Wells Fargo maintained Celgene Corporation (NASDAQ:CELG) on Friday, December 4 with "Outperform" rating. The rating was maintained by Stifel Nicolaus on Thursday, July 20 with "Hold". The firm has "Buy" rating given on Friday, July 24 by Cantor Fitzgerald. Investec maintained Go-Ahead Group plc (LON:GOG) on Friday, September 2 with "Buy" rating.
Westwood Management Corp increased Progressive Corp. About 3,005 shares traded.
Since June 15, 2017, it had 0 insider buys, and 3 insider sales for $2.36 million activity. Shares for $1.16 million were sold by CASEY MICHAEL D. 4,785 shares were sold by VESSEY RUPERT, worth $575,038 on Thursday, June 15. The target price per share suggests a potential upside of 15.01 % from the close price of Celgene (NASDAQ:CELG).
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.
- Monument of Love, the Taj Mahal, at Heart of Political Storm
- Facebook Workplace invades your PC with a new app
- CVS Health Reportedly In Talks To Buy Aetna
- United Nations experts: Assad regime responsible for Syria chemical attack
- Motorcycling-Marquez snatches pole for Australian Grand Prix
- Man arrested for rape and murder of girlfriend's 13-month-old
- Hadiya 'love jihad' case
- Trump rips Democratic donor behind impeachment campaign
- Kathy Griffin slams New Year's replacement Andy Cohen as 'deeply misogynistic'
- Can analysts adopt a bullish outlook for Ford Motor Company (NYSE:F)?
- India aim to clinch series against NZ
- Take stand on quota by November 3: Hardik Patel to Congress
- Revanth Reddy quits TDP